Friday, June 18, 2021 2:19:54 AM
With each added site wouldn't that mean you'd have to account for the 14/28 day treatment regimen from the date of the opening of that new site?
That is unless the sites were added long prior to them being made public or, that these additional sites are part of additional studies being conducted apart from the Mild2Mod Covid trial.
Don't get me wrong, always happy to see new sites go online and believe it's a definite indication things are progressing well, just not sure how it lines up with the timetable for the Buc trial.
That is unless the sites were added long prior to them being made public or, that these additional sites are part of additional studies being conducted apart from the Mild2Mod Covid trial.
Don't get me wrong, always happy to see new sites go online and believe it's a definite indication things are progressing well, just not sure how it lines up with the timetable for the Buc trial.
WELCOME TO UNICORNLAND
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
